Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome

Vaziri, Nosratola D.; Kim, Choong H.; Iphan, Dennis; Kim, Sara; Liang, Kaihui
July 2004
Kidney International;Jul2004, Vol. 66 Issue 1, p262
Academic Journal
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome. Background. Nephrotic syndrome is associated with hypercholesterolemia, hypertriglyceridemia, and marked elevations of plasma low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL). Hypertriglyceridemia in nephrotic syndrome is accompanied by increased hepatic fatty acid synthesis, elevated triglyceride secretion, as well as lipoprotein lipase, VLDL-receptor, and hepatic triglyceride lipase deficiencies, which lead to impaired clearance of triglyceride-rich lipoproteins. Acyl CoA: diacylglycerol acyltransferase (DGAT) is a microsomal enzyme that joins acyl CoA to 1, 2-diacylglycerol to form triglyceride. Two distinct DGATs (DGAT-1 and DGAT2) have recently been identified in the liver and other tissues. The present study tested the hypothesis that the reported increase in hepatic triglyceride secretion in nephrotic syndrome may be caused by up-regulation of DGAT. Methods. Male Sprague-Dawley rats were rendered nephrotic by two sequential injections of puromycin aminonucleoside (130 mg/kg on day 1 and 60 mg/kg on day 14) and studied on day 30. Placebo-treated rats served as controls. Hepatic DGAT-1 and DGAT-2 mRNA abundance and enzymatic activity were measured. Results. The nephrotic group exhibited heavy proteinuria, hypoalbuminemia, hypercholesterolemia, hypertriglyceridemia, and marked elevation of VLDL concentration. Hepatic DGAT-1 mRNA, DGAT-1, and total DGAT activity were significantly increased, whereas DGAT-2 mRNA abundance and activity were unchanged in the nephrotic rats compared to the control animals. The functional significance of elevation of DGAT activity was illustrated by the reduction in microsomal free fatty acid concentration in the liver of nephrotic animals. Conclusion. Nephrotic syndrome results in up-regulation of hepatic DGAT-1 expression and activity, which can potentially contribute to the associated hypertriglyceridemia by enhancing triglyceride synthesis. Thus, it appears that both depressed catabolism and increased synthetic capacity contribute to hypertriglyceridemia of nephrotic syndrome.


Related Articles

  • Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. De Sain-van der Velden, Monique G.; Kaysen, George A.; Barrett, Hugh A.; Stellaard, Frans; Gadellaa, Mireille M.; Voorbij, Hieronymus A.; Reijngoud, Dirk-Jan; Rabelink, Ton J. // Kidney International;Apr1998, Vol. 53 Issue 4, p994 

    Examines the factors affecting the levels of low density proteins. Cause of an increased very LDL in nephrotic patients; Influence of synthesis on the levels of LDL; Hallmark of nephrotic syndrome.

  • Down-regulation of hepatic LDL receptor expression in experimental nephrosis. Vaziri, Nosratola D.; Kai Hui Liang // Kidney International;Sep1996, Vol. 50 Issue 3, p887 

    Nephrotic syndrome (NS) is invariably associated with elevation of plasma total and LDL cholesterol concentrations. The present study was carried out to test the hypothesis that nephrotic LDL hypercholesterulemia is, in part, due to acquired LDL receptor (LDLR) deficiency. To this end, hepatic...

  • Treatment of nephrotic hyperlipoproteinemia with gemfibrozil. Groggel, Gerald C.; Cheung, Alfred K.; Ellis-Benigni, Karen; Wilson, Dana E. // Kidney International;Aug1989, Vol. 36 Issue 2, p266 

    Hypercholesterolemia is a known complication of the nephrotic syndrome. Patients with persistent proteinuria and prolonged hypercholesterolemia are probably at increased risk for cardiovascular disease. Until recently there has been no safe and effective treatment for this disorder. The effects...

  • Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome. Liu, Shuman; Vaziri, Nosratola D. // Nephrology Dialysis Transplantation;Mar2014, Vol. 29 Issue 3, p538 

    Background Nephrotic syndrome (NS) leads to elevation of serum total and LDL cholesterol. This is largely due to impaired LDL clearance, which is caused by hepatic LDL receptor (LDLR) deficiency despite normal LDLR mRNA expression, pointing to a post-transcriptional process. The mechanism(s) by...

  • Response of the Cholesterol Metabolism to a Negative Energy Balance in Dairy Cows Depends on the Lactational Stage. Gross, Josef J.; Kessler, Evelyne C.; Albrecht, Christiane; Bruckmaier, Rupert M. // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    The response of cholesterol metabolism to a negative energy balance (NEB) induced by feed restriction for 3 weeks starting at 100 days in milk (DIM) compared to the physiologically occurring NEB in week 1 postpartum (p.p.) was investigated in 50 dairy cows (25 control (CON) and 25...

  • Hypercholesterolemia and apolipoprotein B expression: Regulation by selenium status. Dhingra, Sanjiv; Bansal, Mohinder P. // Lipids in Health & Disease;2005, Vol. 4, p28 

    Background: Apolipoprotein B (apoB) contains ligand-binding domain for the binding of LDL to LDL-R site, which enables the removal of LDL from circulation. Our recent data showed that selenium (Se) is involved in the lipid metabolism. The present study was aimed to understand the effect of Se...

  • Monogenic hypercholesterolemias: New genes, new drug targets. Mandelshtam, M.; Vasilyev, V. // Russian Journal of Genetics;Oct2008, Vol. 44 Issue 10, p1134 

    This review is focused on recent data on structure and functions of PCSK9 proprotein convertase, a newly identified participant in cholesterol metabolism in mammalian organisms, including humans. Proprotein convertase acts as a molecular chaperone for the low density lipoprotein (LDL) receptor,...

  • Dose and time-dependent hypercholesterolemic effects of iodine excess via TRβ1-mediated down regulation of hepatic LDLr gene expression. Li -Na Zhao; Jian Xu; Xiao-Lin Peng; Li-Yue Tian; Li-Ping Hao; Xue-Feng Yang; Chen-Jiang Ying; Xiu-Fa Sun // European Journal of Nutrition;Aug2010, Vol. 49 Issue 5, p257 

    With the global improvement of iodine nutrition, iodine excess is emerging as a new concern. The aim of this study is to illustrate the physiological effects and potential molecular mechanisms of excessive iodine intake on lipid metabolism. Balb/c mice were given drinking water containing...

  • Tumorouos xanthomas in a young male with familial hypercholdesterolaemia. Rajput, R.; Bhansali, A. // Archives of Disease in Childhood;Oct2006, Vol. 91 Issue 10, p827 

    The article reports on the medical case of a 16-year-old boy who presented with massive bilateral tumorous swellings over his buttocks and who was diagnosed later with tumorous xanthomas with familial hypercholesterolemia. Xanthomas are manifestations of disordered lipid metabolism. Tuberous...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics